|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 139.50 USD | -0.01% |
|
-0.45% | -19.85% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Drug Delivery Technologies | ||||||||||
Development and Commercialization of Therapies for Patients with Rare Diseases | 19Cr | 25Cr | 31Cr | 36Cr | 61Cr | |||||
Total Assets | 124.35Cr | 165.64Cr | 132.98Cr | 202.52Cr | 226.46Cr | |||||
Interest Expense | -4.05Cr | -2.64Cr | -8.14Cr | -8.51Cr | -8.38Cr | |||||
Income Tax Expense | -17.58L | 13.83L | 25.55L | 37.07L | 50.26L | |||||
CAPEX | -72.89L | -98.78L | -1.33Cr | -2.19Cr | -3.26Cr | |||||
EBT | -44Cr | -48Cr | -75Cr | -91Cr | -127.17Cr | |||||
Gross Profit | - | - | - | - | - | |||||
D&A | 1.04Cr | 74.4L | 84.41L | 88.75L | 1.43Cr | |||||
Operating Income | -38Cr | -46Cr | -71Cr | -88Cr | -124.68Cr | |||||
Net Income | -43Cr | -48Cr | -75Cr | -91Cr | -127.68Cr |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 16Cr | 19Cr | 22Cr | 25Cr | 45Cr | |||||
International | - | - | - | - | 15Cr | |||||
Europe and Rest of World | 1.29Cr | 28.58L | 1.53Cr | 2.12Cr | - | |||||
Japan | 1.6Cr | 5.65Cr | 6.57Cr | 8.77Cr | - |
- Stock Market
- Equities
- INSM Stock
- Financials Insmed Incorporated
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition